Although the generics industry promotes its products as therapeutically identical to higher-priced brand name drugs, newly published research now suggests that patient adherence to a therapeutic regimen is higher for patients on generics rather than branded drugs. The study, published in the February 13, 2006, issue of the journal Archives of Internal Medicine, concluded that patients given the generic version of a drug were found to adhere to their treatments better than those prescribed the brand name versions. "After controlling for patient sociodemographic characteristics and drug class, [the proportion of days covered] was 12.6% greater for patients initiated on generic medications," the researchers concluded.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs